Apellis Pharmaceuticals, Inc. (APLS)
23.79
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 16:00
23.79
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Market Cap: 3.010B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 25.81B |
| Amicus Therapeutics, Inc. | 3.025B |
| Fortress Biotech, Inc. | 88.46M |
| Ultragenyx Pharmaceutical, Inc. | 3.500B |
| Fulcrum Therapeutics, Inc. | 789.59M |
Market Cap Related Metrics
| PE Ratio | 80.10 |
| PS Ratio | 2.961 |
| Price to Book Value | 7.503 |
| Price to Free Cash Flow | 38.27 |
| Price | 23.79 |
| Earnings Yield | 1.25% |
| Operating PE Ratio | 37.43 |
| Normalized PE Ratio | 80.10 |